Beyond beauty with cellular skincare
The skincare market is shifting toward clinically substantiated actives with measurable biological outcomes.
Demand is strongest in functional cosmetics and cosmeceuticals - where bioactive peptides, growth-factor-inspired ingredients, and ingredient verification are becoming baseline expectations rather than premium differentiators.
Cosmeutical market size
USD 67.1 Billion
3.9% expected CAGR (2025-2030)
$84.6B by 2032
Cosmeceutical Market (2025 - 2030) \ Grand View Research
From label claims to measurable actives.
Bioactive peptides and recombinant growth factor actives are increasingly specified in cosmetic formulations, but analytical confirmation of identity and purity is uncommon once raw materials pass through multi-step international supply chains. Without ingredient verification at source, brands face performance variability, inconsistent bioactivity, and regulatory claims risk.
Immobazyme resolves this at the point of manufacture. Every batch of sh-Oligopeptide-1, sh-Oligopeptide-2, sh-Polypeptide-1, sh-Polypeptide-22 is characterised and released in-house — identity confirmed by mass spectrometry, purity by SDS-PAGE and HPLC, safety by endotoxin — before it ships.
Verified peptides, manufactured for consistency
Immobazyme manufactures recombinant cosmetic actives and bio-identical peptides using precision fermentation — a production method that programmes a micro-organism to express a single, precisely-defined molecule, then purifies it to a verified specification. The result is cosmetic-grade material with consistent molecular identity, documented bioactivity, and traceable batch provenance — the foundation for substantiated ingredient claims.
High Bioactivity
Confirmed by in-house potency assay on every batch
High Purity
Verified by mass spectrometry and SDS-PAGE
Animal-origin free
Produced by microbial precision fermentation
Batch consistency
Certificate of Analysis supplied with every order
Key Growth Drivers and Trends
Health & Wellness
60%
of consumers across markets report that healthy aging is a “top” or “very important” priority
Efficacy Demand
77%
of beauty users demand proven efficacy from at-home products.
This demonstrates a growth in demand for efficacy and efficiency of at-home treatments.
Medical-grade
45%
Consumers are investing time and money in products that improve their long-term health, not just their immediate appearance
Of Luxury Beauty Shoppers in 2025 are influenced by medical professionals (up from 40% in 2024).
Highlighting that clinical credibility is shaping high-value, purchase decisions.